UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.841

Sortiert nach

Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial

Clinical infectious diseases, 2009-11, Vol.49 (10), p.1591-1601

2009

Link zum Volltext

Verfügbarkeit prüfen

Adverse effects of antiretroviral therapy

The Lancet (British edition), 2000-10, Vol.356 (9239), p.1423-1430

2000

Link zum Volltext

Verfügbarkeit prüfen

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

HIV medicine, 2003-07, Vol.4 (3), p.293-301

2003

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of cognitive change in HIV‐infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study

HIV medicine, 2012-04, Vol.13 (4), p.245-251

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study

Clinical pharmacology and therapeutics, 2015-10, Vol.98 (4), p.406-416

2015

Link zum Volltext

Verfügbarkeit prüfen

Exhaust emissions from ships at berth

Atmospheric environment (1994), 2003-09, Vol.37 (27), p.3817-3830

Cooper, D.A.

2003

Link zum Volltext

Verfügbarkeit prüfen

A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults

Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.402-408

2009

Link zum Volltext

Verfügbarkeit prüfen

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

The New England journal of medicine, 2008-10, Vol.359 (14), p.1442-1455

2008

Link zum Volltext

Verfügbarkeit prüfen

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

AIDS (London), 2007-11, Vol.21 (18), p.2445-2453

2007

Link zum Volltext

Verfügbarkeit prüfen

Carotenoids in Health and Disease: Recent Scientific Evaluations, Research Recommendations and the Consumer

The Journal of nutrition, 2004-01, Vol.134 (1), p.221S-224S

Cooper, Dale A.

2004

Link zum Volltext

Verfügbarkeit prüfen

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults : the first 4 years

AIDS (London), 2007-06, Vol.21 (10), p.1273-1281

2007

Link zum Volltext

Verfügbarkeit prüfen

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy : contribution to protease inhibitor-related lipodystrophy syndrome

AIDS (London), 2000-02, Vol.14 (3), p.F25-F32

2000

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2006-12, Vol.43 (5), p.509

2006

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

AIDS (London), 2007-11, Vol.21 (17), p.2315-2321

2007

Link zum Volltext

Verfügbarkeit prüfen

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

Annals of internal medicine, 1992-07, Vol.117 (2), p.106

1992

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

AIDS (London), 2003-05, Vol.17 (7), p.971-979

2003

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus : a cohort study

The Lancet (British edition), 1999-06, Vol.353 (9170), p.2093-2099

1999

Link zum Volltext

Verfügbarkeit prüfen

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

AIDS (London), 2004-04, Vol.18 (7), p.1029-1036

2004

Link zum Volltext

Verfügbarkeit prüfen

Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection

The American journal of clinical nutrition, 2004-08, Vol.80 (2), p.396-403

2004

Link zum Volltext

Verfügbarkeit prüfen

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

AIDS (London), 1998-05, Vol.12 (7), p.F51-F58

1998

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

The Lancet (British edition), 1998-06, Vol.351 (9119), p.1881-1883

1998

Link zum Volltext

Verfügbarkeit prüfen

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

AIDS (London), 2011-11, Vol.25 (17), p.2069-2078

2011

Link zum Volltext

Verfügbarkeit prüfen

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

Clinical infectious diseases, 2010-03, Vol.50 (6), p.920-929

2010

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2002-07, Vol.288 (2), p.222

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.841

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.632)
Mit Volltextzugriff
(1.580)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.758)
Japanisch
(302)
Portugiesisch
(57)
Norwegisch
(21)
Italienisch
(14)
Bokmål, Norwegian; Norwegian Bokmål
(14)
Deutsch
(6)
Spanisch
(6)

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.295)
Life Sciences & Biomedicine
(1.035)
Humans
(819)
Biological And Medical Sciences
(587)
Male
(505)
Medical Sciences
(467)
Female
(414)
Adult
(381)
Infectious Diseases
(254)
Aids/hiv
(247)
Middle Aged
(234)
Immunology
(225)
Animals
(206)
Physical Sciences
(154)
Human Immunodeficiency Virus
(140)
Hiv Infections - Drug Therapy
(139)
Hiv
(133)
Aged
(129)
Fundamental And Applied Biological Sciences. Psychology
(125)
Virology
(115)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial

Adverse effects of antiretroviral therapy

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

Dynamics of cognitive change in HIV‐infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study

Exhaust emissions from ships at berth

A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

Carotenoids in Health and Disease: Recent Scientific Evaluations, Research Recommendations and the Consumer

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults : the first 4 years

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy : contribution to protease inhibitor-related lipodystrophy syndrome

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus : a cohort study

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel

Suchergebnisse filtern